Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Jonathan Darrow, S.J.D.

Concepts (129)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Drug Approval2420218186.870 Why?
United States Food and Drug Administration26202116265.100 Why?
Drug Industry1320218984.130 Why?
Government Regulation820215503.130 Why?
Patents as Topic920211453.050 Why?
Drugs, Generic920204422.810 Why?
Drugs, Investigational720182332.390 Why?
Pharmaceutical Preparations820208711.740 Why?
Drug Costs6202110861.440 Why?
Prescription Drugs520215591.370 Why?
Legislation, Drug320202121.350 Why?
Investigational New Drug Application32018171.350 Why?
Public Sector220212580.920 Why?
Drug Discovery5202010190.920 Why?
Device Approval120211900.780 Why?
Federal Government120202720.770 Why?
United States362021632180.770 Why?
Retinal Dystrophies12019480.760 Why?
Commerce320206020.760 Why?
Pharmacists120202120.720 Why?
Leukemia, B-Cell12017770.710 Why?
Drug Substitution120202670.710 Why?
Muscular Atrophy, Spinal120202570.700 Why?
Medicare Part D120212660.680 Why?
Bioethical Issues220151220.670 Why?
Private Sector120193770.660 Why?
Surgical Procedures, Operative2202019180.660 Why?
Biotechnology120193000.650 Why?
National Health Programs120194370.640 Why?
Anti-Infective Agents220209120.630 Why?
Biological Products220206300.620 Why?
History, 20th Century6202128650.570 Why?
History, 21st Century6202115410.560 Why?
Informed Consent120219450.560 Why?
Drug and Narcotic Control320211420.560 Why?
Public Health2201722430.500 Why?
Scientific Misconduct12013710.490 Why?
Consumer Product Safety120131370.480 Why?
Clinical Trials as Topic5202179740.470 Why?
Health Expenditures3202020870.470 Why?
Vision Disorders120199630.460 Why?
Drugs, Essential12011600.430 Why?
Costs and Cost Analysis3202115990.430 Why?
Receptors, Antigen, T-Cell1201723420.380 Why?
Drug Design1201411340.380 Why?
Health Policy3201725680.370 Why?
Biomedical Research2202131590.370 Why?
Vaccines120155500.370 Why?
Health Services Accessibility3201547730.370 Why?
Therapeutic Equivalency220201520.360 Why?
Evidence-Based Medicine1202037580.360 Why?
Economic Competition220202310.340 Why?
Financing, Government220204860.320 Why?
Periodicals as Topic1201814480.320 Why?
Humans4320216607310.310 Why?
Antineoplastic Agents22019135980.300 Why?
General Surgery1201716500.290 Why?
Internationality120119840.290 Why?
Coronavirus Infections2202032350.290 Why?
Product Surveillance, Postmarketing220214610.260 Why?
Anti-Retroviral Agents1201315060.250 Why?
Neoplasms32019184760.250 Why?
Delivery of Health Care1201942560.240 Why?
Pandemics1202051070.240 Why?
Capital Financing12021540.230 Why?
Pneumonia, Viral1202033500.230 Why?
Legislation, Medical120211000.230 Why?
Legislation, Pharmacy1202030.230 Why?
Government120211370.220 Why?
Intellectual Property12020460.220 Why?
Protective Clothing120201050.210 Why?
Safety-Based Drug Withdrawals12020440.210 Why?
Economics, Pharmaceutical12020900.210 Why?
cis-trans-Isomerases12019390.200 Why?
Chile120192100.200 Why?
Time Factors72021418420.190 Why?
Morals120212320.190 Why?
Drug Repositioning120201800.190 Why?
Adenosine Monophosphate120202610.190 Why?
Resource Allocation120213610.190 Why?
Ownership120202900.180 Why?
Alanine120205440.180 Why?
Medical Staff Privileges12017180.180 Why?
Health Care Sector120191850.170 Why?
Economics120171530.170 Why?
Financing, Personal120193170.170 Why?
Credentialing120171290.160 Why?
Canada1202018460.150 Why?
Ethics, Medical120208140.150 Why?
Immunity, Herd12015410.150 Why?
Clinical Trials, Phase II as Topic120176030.150 Why?
Alzheimer Disease1201363640.140 Why?
Rare Diseases120184610.130 Why?
Randomized Controlled Trials as Topic2202090550.120 Why?
Europe1201932030.120 Why?
Remission Induction1201723610.120 Why?
Immunotherapy, Adoptive120178090.110 Why?
Databases, Factual3202075150.100 Why?
Forecasting1201929280.100 Why?
Policy Making120135360.100 Why?
Terminology as Topic1201716530.090 Why?
Regression Analysis1201866910.090 Why?
Software1202142400.080 Why?
India1201321290.080 Why?
Decision Making1202138400.080 Why?
Models, Theoretical1201836040.080 Why?
Cohort Studies22018371210.070 Why?
Cytokines1201770060.060 Why?
Aged320211569370.050 Why?
Risk Assessment22020229230.040 Why?
Immunization1202012510.040 Why?
Cost Savings120209110.040 Why?
Child22020687860.030 Why?
Statistics, Nonparametric1201830310.030 Why?
Data Collection1202032970.030 Why?
Cross-Sectional Studies22020203900.030 Why?
Insurance, Health1202023980.020 Why?
HIV Infections12013148250.020 Why?
Molecular Targeted Therapy1201827310.020 Why?
Medicaid1201823880.020 Why?
Registries1201876220.010 Why?
Reproducibility of Results12018189210.010 Why?
Aged, 80 and over12020576800.010 Why?
Young Adult12020540780.010 Why?
Adolescent12020827960.010 Why?
Male220203439170.010 Why?
Female220203651990.010 Why?
Adult120202062950.000 Why?
Middle Aged120202107470.000 Why?
Darrow's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (129)
Explore
_
Co-Authors (9)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.